Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASH 2024 | Racial disparities in multiple myeloma and access to stem cell transplantation

Joselle Cook, MBBS, Mayo Clinic, Rochester, MN, comments on the racial disparities in multiple myeloma regarding access to stem cell transplantation (SCT), highlighting the importance of optimizing transplant for patients. Dr Cook notes that despite advances in treatment, SCT remains a standard of care for upfront treatment, and disparities in access have been identified, with factors such as income and insurance playing a role. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.